22nd Century Group Inc (NASDAQ:XXII)

2.24
Delayed Data
As of 3:59pm ET
 -0.03 / -1.32%
Today’s Change
1.42
Today|||52-Week Range
4.17
-27.51%
Year-to-Date
This Little-Known Tobacco Stock Is Getting a Huge Boost
Jun 26 / MotleyFool.com - Paid Partner Content
If Biden Nixes Nicotine, 22nd Century Group Stock Could 10X
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.27
Today’s open2.27
Day’s range2.20 - 2.32
Volume75,090
Average volume (3 months)1,949,334
Market cap$348.8M
Data as of 3:59pm ET, 07/06/2022

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-1.19%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+10.09%
P/E ratioNM
Price/Sales15.60
Price/Book5.23

Competitors

----
BLUEbluebird bio Inc-0.21-4.26%
MGTXMeiraGTx Holdings PL...+0.32+4.09%
BTAIBioXcel Therapeutics...+1.21+8.23%
Data as of 4:00pm ET, 07/06/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$30.9M
Annual profit (last year)-$32.6M
Net profit margin-105.37%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Buffalo, New York

Forecasts